Oncology, cancer prevention, tumor biology, and immunotherapy relevant to longevity
635 articoli
Pre-treatment gut microbiome signatures predicted cancer recurrence in 674 melanoma patients receiving immune checkpoint blockade, with AUC up to 0.94.
New research reveals how RBM39 protein enhances DNA repair in liver cancer cells, suggesting combination therapy targets.
New study reveals combination therapy targeting ATR and DNA-PKcs kinases dramatically improves radiation response in ATM-deficient prostate cancers.
Researchers discover how SIRT6 protein overcomes temozolomide resistance in deadly brain cancer by modifying histone lactylation patterns.
Researchers find that combining Ganoderma lucidum and Sanghuangporus vaninii extracts may fight colorectal cancer through vitamin D and Wnt pathways.
Study maps hepatitis B virus DNA integration sites in liver cancer, revealing distinct patterns that predict patient outcomes.
Study of 183 brain tumor samples reveals distinct telomere maintenance patterns that could guide personalized cancer therapy.
Study reveals altered FTO enzyme activity and RNA modifications in clear cell renal carcinoma, suggesting new diagnostic markers.
New computational advances help identify which tumor peptides trigger immune responses, potentially revolutionizing personalized cancer therapy.
New research reveals how progenitor cells drive the transition from benign to malignant cancer, offering potential intervention targets.
Quantum computing breakthrough accelerates development of photodynamic therapy drugs for cancer treatment in major healthcare competition.
Breakthrough antibodies completely prevent EBV infection in lab models, offering hope against virus linked to cancer and chronic disease.
